ResearcherVan Andel InstituteActive in the last 2 years
ChongFeng Gao
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples. Co-author DOI 10.1126/sciadv.adt0029↗
- Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1135405↗
- Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Co-author DOI 10.1158/1078-0432.ccr-20-2475↗
- The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Co-author DOI 10.1158/1078-0432.ccr-18-3310↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brian B. Haab · 4 shared papers, 2019–2025 · strength 0.59
- Paper Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer. DOI 10.3389/fonc.2023.1135405↗
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Peter J. Allen · 3 shared papers, 2021–2025 · strength 0.51
- Paper Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer. DOI 10.3389/fonc.2023.1135405↗
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Chanjuan Shi · 2 shared papers, 2023–2025 · strength 0.40
- Ben Staal · 3 shared papers, 2019–2025 · strength 0.38
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Randall E. Brand · 3 shared papers, 2019–2025 · strength 0.38
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Aatur Dilip Singhi · 3 shared papers, 2019–2025 · strength 0.38
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Ying Huang · 3 shared papers, 2019–2025 · strength 0.38
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Luke Wisniewski · 2 shared papers, 2021–2023 · strength 0.31
- Braelyn Binkowski · 1 shared paper, 2025 · strength 0.20
- Steve Gallinger · 1 shared paper, 2025 · strength 0.20
- Daniel Barnett · 2 shared papers, 2019–2021 · strength 0.18
- Richard R. Drake · 2 shared papers, 2019–2021 · strength 0.18
- Ying Liu · 1 shared paper, 2021 · strength 0.10
- Amer H. Zureikat · 1 shared paper, 2021 · strength 0.10
- Mohammed Aldakkak · 1 shared paper, 2021 · strength 0.10
- Douglas B. Evans · 1 shared paper, 2021 · strength 0.10
- Susan Tsai · 1 shared paper, 2021 · strength 0.10
- David Arthur Tuveson · 1 shared paper, 2021 · strength 0.10
- Anirban Maitra · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.